GLP-1 Medication Titration: When to Increase and When to Stay at Your Current Dose Lori Fauquier, APN-C, WHNP Feb 6, 2025 3 min read Updated: Jun 7, 2025 GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have revolutionized medical weight loss, helping individuals control cravings, regulate blood sugar, and achieve sustainable weight loss
for example, they should anticipate blue-green urine and possibly a change in how things taste
TGA head Adjunct Professor John Skerritt said regulators were also worried about a heightened risk of skin cancer from misuse of the drug, while British medical authorities have listed acne, kidney, brain and heart problems as side effects
Aliquots were spotted onto P81 phosphocellulose filters, which were then washed three times for 10 min each in 75 mM phosphoric acid, followed by a 5-min wash in methanol